On March 27, 2014, the New York Times published an editorial in support of a proposed change to the U.S. Food and Drug Administration’s (FDA) rules governing labeling of generic drugs. The e... Read more
Hyundai Motor America has dropped a policy requiring that some warranty coverage disputes between customers and the factory be settled through arbitration. In other words the carmaker is tak... Read more
UBS, the Swiss banking giant, entered into a record settlement with global authorities last month, agreeing to a combined $1.5 billion in fines for its role in a multi-year scheme to manipul... Read more
When the U.S. Food and Drug Administration released the result of a Mini-Sentinel assessment of Pradaxa, the new-age anti-clotting agent that serves as an alternative to the 60-year-old stan... Read more
But it should be noted that there are other health and safety issues facing drug manufacturers. In the last three years, six of the major manufacturers of sterile injectable drugs — which ar... Read more
GFI Mortgage Bankers has agreed to pay more than $3.5 million to settle allegations by federal prosecutors that it charged higher interest rates and fees on mortgages to nonwhite borrowers t... Read more
Even though election day in the general election is still months away, we are already being bombarded on television by blistering political attacks masquerading as “issue ads.” These ads are... Read more
According to all recent polls, members of Congress face historically low approval ratings, which should come as no big surprise. A most recent poll revealed that just 12% of Americans now ap... Read more
Thousands of Public Citizen’s supporters signed a petition recently demanding that AIG return the $534,000 executives spent to pamper themselves. The petition was sent to the bosses at... Read more
Biogen Idec and Elan Corporation have reported two cases of a rare brain disease in patients treated with Tysabri, which is the companies’ multiple sclerosis drug. The cases of progres... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.